cystic fibrosis lung Latest Research Papers

Novel Anti-inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

10.3389/978-2-88971-941-9 ◽

2022 ◽

Keyword(s):

Cystic Fibrosis ◽

Lung Disease ◽

Molecular Targets ◽

Cystic Fibrosis Lung ◽

Disease Identification ◽

Cystic Fibrosis Lung Disease ◽

Innovative Therapies ◽

Anti Inflammatory

Get full-text (via PubEx)

Developing Ciprofloxacin Dry Powder for Inhalation: A Story of Challenges and Rational Design in the Treatment of Cystic Fibrosis Lung Infection

International Journal of Pharmaceutics ◽

10.1016/j.ijpharm.2021.121388 ◽

2021 ◽

pp. 121388

Author(s):

Nasser Alhajj ◽

Niall J. O'Reilly ◽

Helen Cathcart

Keyword(s):

Cystic Fibrosis ◽

Rational Design ◽

Lung Infection ◽

Cystic Fibrosis Lung ◽

Dry Powder

Get full-text (via PubEx)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

Frontiers in Pharmacology ◽

10.3389/fphar.2021.794854 ◽

2021 ◽

Vol 12 ◽

Author(s):

Carla Maria Pedrosa Ribeiro ◽

Noel Gerard McElvaney ◽

Giulio Cabrini

Keyword(s):

Cystic Fibrosis ◽

Lung Disease ◽

Molecular Targets ◽

Cystic Fibrosis Lung ◽

Disease Identification ◽

Cystic Fibrosis Lung Disease ◽

Innovative Therapies ◽

Anti Inflammatory

Get full-text (via PubEx)

S58 Triple CFTR modulators improve sino-nasal and laryngopharyngeal reflux symptoms in people with advanced cystic fibrosis lung disease

10.1136/thorax-2021-btsabstracts.64 ◽

2021 ◽

Author(s):

S Shakir ◽

C Echevarria ◽

S Doe ◽

M Brodlie ◽

C Ward ◽

...

Keyword(s):

Cystic Fibrosis ◽

Lung Disease ◽

Laryngopharyngeal Reflux ◽

Cystic Fibrosis Lung ◽

Reflux Symptoms ◽

Cystic Fibrosis Lung Disease ◽

Cftr Modulators

Get full-text (via PubEx)

426: Biointerfacing drug carriers for enhanced delivery of synergistic antimicrobials to treat cystic fibrosis lung infections

Journal of Cystic Fibrosis ◽

10.1016/s1569-1993(21)01850-6 ◽

2021 ◽

Vol 20 ◽

pp. S200

Author(s):

J. Finbloom ◽

M. Yu ◽

T. Desai

Keyword(s):

Cystic Fibrosis ◽

Drug Carriers ◽

Cystic Fibrosis Lung ◽

Lung Infections

Get full-text (via PubEx)

499: Bacteriophage therapy decreases cystic fibrosis lung inflammation

Journal of Cystic Fibrosis ◽

10.1016/s1569-1993(21)01923-8 ◽

2021 ◽

Vol 20 ◽

pp. S235-S236

Author(s):

G. Stanley ◽

M. Modak ◽

K. Kortright ◽

I. Ott ◽

Y. Sun ◽

...

Keyword(s):

Cystic Fibrosis ◽

Lung Inflammation ◽

Cystic Fibrosis Lung ◽

Bacteriophage Therapy

Get full-text (via PubEx)

359: Flow cytometry approaches to analyze lymphocytes in cystic fibrosis lung airways

Journal of Cystic Fibrosis ◽

10.1016/s1569-1993(21)01783-5 ◽

2021 ◽

Vol 20 ◽

pp. S171

Author(s):

S. Measner ◽

S. McGettigan ◽

G. Debes ◽

M. Stephen

Keyword(s):

Cystic Fibrosis ◽

Flow Cytometry ◽

Cystic Fibrosis Lung ◽

Lung Airways

Get full-text (via PubEx)

549: LUNAR-CF: A novel mRNA therapeutic approach to correct the root cause of cystic fibrosis lung disease

Journal of Cystic Fibrosis ◽

10.1016/s1569-1993(21)01972-x ◽

2021 ◽

Vol 20 ◽

pp. S259

Author(s):

C. Perez-Garcia ◽

Y. Pei ◽

Y. Bao ◽

P. Karmali ◽

X. Liu ◽

...

Keyword(s):

Cystic Fibrosis ◽

Lung Disease ◽

Therapeutic Approach ◽

Cystic Fibrosis Lung ◽

Root Cause ◽

Cystic Fibrosis Lung Disease

Get full-text (via PubEx)

495: Investigation of the pediatric cystic fibrosis lung mycobiome using paired sputum induction and bronchoalveolar lavage samples shows individual heterogeneity but sampling method equivalence

Journal of Cystic Fibrosis ◽

10.1016/s1569-1993(21)01919-6 ◽

2021 ◽

Vol 20 ◽

pp. S234

Author(s):

R. Weiser ◽

E. Mahenthiralingam ◽

J. Forton

Keyword(s):

Cystic Fibrosis ◽

Bronchoalveolar Lavage ◽

Sampling Method ◽

Cystic Fibrosis Lung ◽

Individual Heterogeneity ◽

Sputum Induction ◽

Method Equivalence

Get full-text (via PubEx)

173: Separating wheat from chaff: Hypercubes to identify proteins predictive of rapid cystic fibrosis lung disease progression

Journal of Cystic Fibrosis ◽

10.1016/s1569-1993(21)01598-8 ◽

2021 ◽

Vol 20 ◽

pp. S85-S86

Author(s):

Y. Cheng ◽

A. Ziady ◽

M. Siefert ◽

E. Skala ◽

R. Szczesniak ◽

...

Keyword(s):

Cystic Fibrosis ◽

Lung Disease ◽

Disease Progression ◽

Cystic Fibrosis Lung ◽

Cystic Fibrosis Lung Disease

Get full-text (via PubEx)

cystic fibrosis lung
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Novel Anti-inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

Developing Ciprofloxacin Dry Powder for Inhalation: A Story of Challenges and Rational Design in the Treatment of Cystic Fibrosis Lung Infection

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

S58 Triple CFTR modulators improve sino-nasal and laryngopharyngeal reflux symptoms in people with advanced cystic fibrosis lung disease

426: Biointerfacing drug carriers for enhanced delivery of synergistic antimicrobials to treat cystic fibrosis lung infections

499: Bacteriophage therapy decreases cystic fibrosis lung inflammation

359: Flow cytometry approaches to analyze lymphocytes in cystic fibrosis lung airways

549: LUNAR-CF: A novel mRNA therapeutic approach to correct the root cause of cystic fibrosis lung disease

495: Investigation of the pediatric cystic fibrosis lung mycobiome using paired sputum induction and bronchoalveolar lavage samples shows individual heterogeneity but sampling method equivalence

173: Separating wheat from chaff: Hypercubes to identify proteins predictive of rapid cystic fibrosis lung disease progression

Export Citation Format

cystic fibrosis lungRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Novel Anti-inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

Developing Ciprofloxacin Dry Powder for Inhalation: A Story of Challenges and Rational Design in the Treatment of Cystic Fibrosis Lung Infection

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

S58 Triple CFTR modulators improve sino-nasal and laryngopharyngeal reflux symptoms in people with advanced cystic fibrosis lung disease

426: Biointerfacing drug carriers for enhanced delivery of synergistic antimicrobials to treat cystic fibrosis lung infections

499: Bacteriophage therapy decreases cystic fibrosis lung inflammation

359: Flow cytometry approaches to analyze lymphocytes in cystic fibrosis lung airways

549: LUNAR-CF: A novel mRNA therapeutic approach to correct the root cause of cystic fibrosis lung disease

495: Investigation of the pediatric cystic fibrosis lung mycobiome using paired sputum induction and bronchoalveolar lavage samples shows individual heterogeneity but sampling method equivalence

173: Separating wheat from chaff: Hypercubes to identify proteins predictive of rapid cystic fibrosis lung disease progression

cystic fibrosis lung
Recently Published Documents